BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, January 10, 2025
Home
»
Topics
»
Disease categories and therapies
» Ocular
Ocular
RSS
Anecortave acetate study results
Oct. 18, 2004
No Comments
Cand5 enters phase I study for AMD
Oct. 14, 2004
No Comments
Photrex chosen as new brand name for SnET2
Oct. 11, 2004
No Comments
Squalamine granted fast track status for wet AMD
Oct. 7, 2004
No Comments
Therapeutic benefits of omalizumab in allergy conjunctivitis
Oct. 6, 2004
No Comments
Approvable letter for SnET2 for AMD
Oct. 5, 2004
No Comments
ISTA and Allergan sign new Vitrase agreement
Oct. 4, 2004
No Comments
Expanded phase II trial for squalamine opens enrollment
Oct. 1, 2004
No Comments
ISTA Pharmaceuticals' Vitrase granted three-year market exclusivity
Sep. 23, 2004
No Comments
The EMEA accepts marketing authorization application for Macugen
Sep. 23, 2004
No Comments
Previous
1
2
…
309
310
311
312
313
314
315
316
317
…
382
383
Next
RSS